SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-052436
Filing Date
2024-06-13
Accepted
2024-06-13 16:01:54
Documents
72
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0207328-6k_clear.htm   iXBRL 6-K 17835
2 CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND SIX MONTHS ea020732801ex99-1_clear.htm   iXBRL EX-99.1 593732
3 MANAGEMENT'S DISCUSSION AND ANALYSIS FOR THE FOR THE THREE AND SIX MONTHS ENDED ea020732801ex99-2_clear.htm EX-99.2 165432
  Complete submission text file 0001213900-24-052436.txt   4635258

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cmnd-20240430.xsd EX-101.SCH 83561
5 XBRL CALCULATION FILE cmnd-20240430_cal.xml EX-101.CAL 34203
6 XBRL DEFINITION FILE cmnd-20240430_def.xml EX-101.DEF 252166
7 XBRL LABEL FILE cmnd-20240430_lab.xml EX-101.LAB 477621
8 XBRL PRESENTATION FILE cmnd-20240430_pre.xml EX-101.PRE 261625
76 EXTRACTED XBRL INSTANCE DOCUMENT ea0207328-6k_clear_htm.xml XML 657595
Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Filer) CIK: 0001892500 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 6-K | Act: 34 | File No.: 001-41557 | Film No.: 241041173
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)